medigraphic.com
ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio

2012, Number 03-04

Next >>

Medicina & Laboratorio 2012; 18 (03-04)

Cáncer de estómago: le llega el turno para su prevención

Language: Spanish
References: 16
Page: 107-108
PDF size: 107.58 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Graham DY. The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet 1997; 350: 70-71.

  2. Warren J, Marshall B. Unidentified curved baccilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1273-1275.

  3. GLOBOCAN. Cancer incidence, mortality and prevalence worldwide in 2008. http://globocan.iarc.fr/ Consultado el 16 de junio de 2012.

  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.

  5. GLOBOCAN. Cancer incidence, mortality and prevalence worldwide in 2008. Fast stats Colombia. http://globocan. iarc.fr/factsheet.asp Consultado el 16 de junio de 2012.

  6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.

  7. Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: A State-of-the- Art Critique. Am J Gastroenterol 2005; 100: 2100-2115.

  8. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23: 351-365.

  9. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15: 1-20.

  10. Hunt R, Fallone C, Veldhuyzan van Zanten S, Sherman P, Smaill F, Flook N, et al. Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection. Can J Gastroenterol 2004; 18: 547-554.

  11. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664.

  12. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.

  13. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. Jama 2004; 291: 187-194.

  14. Yeh JM, Kuntz KM, Ezzati M, Goldie SJ. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer 2009; 124: 157-166.

  15. Asaka M, Kato M, Graham DY. Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med 2010; 49: 633-636.

  16. República de Colombia, Comisión de Regulación en Salud. Acuerdo número 029 de diciembre 2011 “Por el cual se sustituye el Acuerdo 028 de 2010 que define, aclara y actualiza integralmente el Plan Obligatorio de Salud




2020     |     www.medigraphic.com